{
  "id": "TNM_Breast.v1",
  "gdl_version": "2.0",
  "concept": "gt0001",
  "language": {
    "original_language": "ISO_639-1::en"
  },
  "description": {
    "original_author": {
      "date": "2017-06-16",
      "name": "Syeeda S Farruque",
      "organisation": "Cambio Healthcare Systems",
      "email": "syeeda.farruque@cambiocds.com"
    },
    "other_contributors": [
      "Dennis Forslund, Cambio Healthcare Systems",
      "Linda Guttormsdottir"
    ],
    "lifecycle_state": "Author draft",
    "details": {
      "sv": {
        "id": "sv",
        "purpose": "American Joint Committee on Cancers (AJCC) TNM-klassifikation beskriver allvarlighetsgrad av bröstcancer baserat på tumörstorlek, lymfkörtelengagemang och förekomst av metastaser.",
        "keywords": [
          "TNM",
          "TNM-klassifikation",
          "bröstcancer",
          "cancer",
          "onkologi"
        ],
        "use": "TNM-klassifikation används för bröstcancer efter genomförd biopsi, med syfte att stadieindela och få prognostisk information. Riktlinjerna uppdateras kontinuerligt av National Comprehensive Cancer Network (3). \n\nStadieindelningen av bröstcancer inkluderar detaljerade subgrupper vilka i korthet beskrivs nedan. För vidare detaljer, vänligen se AJCC:s information (1). \n\nStadieindelningen baseras på följande grundläggande faktorer:\n\n•Primärturmör (T)\n•Regionalt lymfkörtelengagemang (N) \no    Kliniskt\no    Patologiskt\n•Fjärrmetastaser (M)\n\nT\nTX: primärtumör kan inte fastställas.\nT0: ingen primärtumör påvisad.\nTis: Carcinoma in situ (DCIS, LCIS, eller Pagets sjukdom utan associerad tumör)\nT1 (inkluderar T1a, T1b, och T1c): tumören är 2 cm eller mindre.\nT2: tumören är större än 2 cm men inte större än 5 cm.\nT3: tumören är större än 5 cm.\nT4 (inkluderar T4a, T4b, T4c, och T4d): tumör som oavsett storlek invaderat bröstväggen eller hud. Inflammatorisk bröstcancer ingår i detta stadium.\n\nN\nEtt område av spridd cancer <0,2mm (eller färre än 200 celler) påverkar inte stadieindelningen. Dessa registreras med förkortningar (i+ eller mol+) vilka indikerar vilken sorts test som användes för att lokalisera spridningen. \n\nOm området av spridd cancer istället är ≥ 0,2mm (eller 200 celler), men inte större än 2 cm, kallas det mikrometastas. Dessa räknas endast om det inte finns större områden av spridd cancer (>2cm).\n\nNX: regionalt lymfkörtelengagemang kan ej fastställas.\nN0: inga tumörceller har kunnat påvisas i regionala lymfkörtlar.\nN0(i+): spridning påvisad med immunhistokemi, <200 celler och <0,2mm [“i+” = förekomst av lågt antal isolerade tumörceller].\nN0(mol+): cancerceller kan ej lokaliseras i regionala lymfkörtlar men spår av cancerceller har påvisats genom bruk av RT-PCR.\nN1: spridning till 1-3 lymfkörtlar i axillen, och/eller mindre massa cancer i bröstets lymfkörtlar.\nN1mi: mikrometastaser i 1-3 lymfkörtlar i axillen; som mest 2mm stora områden (men minst 200 celler/0,2mm).\nN1a: spridning till 1-3 av axillens lymfkörtlar, med minst ett område större än 2mm.\nN1b: spridning till bröstets lymfkörtlar, som endast kunnat påvisas genom portvaktsbiopsi (sentinel node biopsy).\nN1c: både N1a och N1b uppfyllt.\nN2: spridning till 4-9 av axillens lymfkörtlar, eller förstoring av påverkade lymfkörtlar i bröstet (antingen N2a eller N2b, men ej båda). \nN2a: spridning till 4-9 av axillens lymfkörtlar, med minst ett område större än 2mm.\nN2b: spridning till minst en av bröstets lymfkörtlar, med förstoring av denna/dessa som resultat.\nN3 – någon av följande:\nN3a: spridning till minst 10 av axillens lymfkörtlar, med minst ett område större än 2mm, ELLER spridning till lymfkörtlar vid nyckelbenet inklusive minst ett område större än 2mm.\nN3b: tumörceller påvisade i minst en av axillens lymfkörtlar (med minst ett område större än 2mm) och förstorade lymfkörtlar i bröstet, ELLER spridning till minst fyra av axillens lymfkörtlar (med minst ett område större än 2mm) och mindre mängd tumörceller påvisade vid portvaktsbiopsi.\nN3c: spridning till lymfkörtlar ovan nyckelbenet, med minst ett område större än 2mm.\n\nM\nMX: förekomst av fjärrmetastaser kan ej faställas.\nM0: inga fjärrmetastaser har kunnat påvisas genom bilddiagnostik eller klinisk undersökning.\ncM0(i+): mindre mängd tumörceller har påvisats i blod eller benmärg, eller i lymfkörtlar bortom bröst och portvaktskörtlar (ej större än 0,2mm).\nM1: spridning till andra organ; vanligen skelett, lungor, hjärna eller lever.\n\nStadieindelning:\n\nStadium \tT \tN \tM\n0 \tTis \tN0 \tM0\nIA \tT1 \tN0 \tM0\nIB \tT0 \tN1mi \tM0\n\tT1 \tN1mi \tM0\nIIA \tT0 \tN1 \tM0\n\tT1 \tN1 \tM0\n\tT2 \tN0 \tM0\nIIB \tT2 \tN1 \tM0\n\tT3 \tN0 \tM0\nIIIA \tT0 \tN2 \tM0\n\tT1 \tN2 \tM0\n\tT2 \tN2 \tM0\n\tT3 \tN1 \tM0\n\tT3 \tN2 \tM0\nIIIB \tT4 \tN0 \tM0\n\tT4 \tN1 \tM0\n\tT4 \tN2 \tM0\nIIIC \tAny T \tN3 \tM0\nIV \tAny T \tAny N \tM1\n\n\n",
        "misuse": "TNM-klassifikation kräver data inhämtad med hjälp av högkvalitativa metoder inklusive bilddiagnostik och omfattande lymfkörtelundersökning. ",
        "copyright": "© Cambio Healthcare Systems"
      },
      "en": {
        "id": "en",
        "purpose": "The American Joint Committee on Cancer (AJCC) TNM staging system reports on the severity of breast cancer based on tumor, lymph node and metastasis characteristics. The characteristics of the size of the tumour, the extent of spread to local lymph nodes and body organs. These aspects are captured in 3 ways that make up the mnemonic TNM: T: Tumour size; N: Number of regional lymph nodes affected and M: whether the cancer has spread/metastasised beyond the primary organ and regional nodes. Each major category is further subdivided to help classify the picture further. These subdivisions are given suffixes or numbered as shown below.",
        "keywords": [
          "TNM breast cancer staging",
          "breast cancer",
          "cancer",
          "oncology"
        ],
        "use": "The TNM staging system is used with breast cancer patients post biopsy. The system allows clinicians to provide staging and prognosis information on their patients and the TNM staging system for breast cancer is regularly updated through the NCCN (National Comprehensive Cancer Network) breast staging guidelines (3)\n\nBreast cancer staging has several detailed subdivisions which are briefly described below. For more detail, please look at the AJCC staging information. (1)\n\nStaging based on multiple factors including:\n\nPrimary Tumor (T) characteristics\nRegional lymph nodes (N)\n     Clinical\n      Pathological\nDistant metastasis (M)\n\nThe Tumor (T) Node (N) Metastases (M) classification diversifies further in Breast cancer staging as follows:\n\nT\nTX: Primary tumor cannot be assessed.\nT0: No evidence of primary tumor.\nTis: Carcinoma in situ (DCIS, LCIS, or Paget disease of the nipple with no associated tumor mass)\nT1 (includes T1a, T1b, and T1c): Tumor is 2 cm (3/4 of an inch) or less across.\nT2: Tumor is more than 2 cm but not more than 5 cm (2 inches) across.\nT3: Tumor is more than 5 cm across.\nT4 (includes T4a, T4b, T4c, and T4d): Tumor of any size growing into the\nchest wall or skin. This includes inflammatory breast cancer.\n\nN\nAn area of cancer spread < 0.2 mm (or fewer than 200 cells) doesn't affect the stage, but is recorded with abbreviations (i+ or mol+) that indicate the type of special test used to find the spread but this level of staging does not affect the overall staging classification of the N subset.\nIf the area of cancer spread is > = 0.2 mm (or 200 cells), but still not larger than 2 mm, it is called a micrometastasis. Micrometastases are counted only if there aren't any larger areas of cancer spread (> 2mm).\n\nNX: Nearby lymph nodes cannot be assessed\nN0: Cancer has not spread to nearby lymph nodes.\nN0(i+): Cancer spread < 200 cells and is < 0.2 mm [\\\"i+\\\" = presence of small numbers of isolated tumor cells) in immunohistochemistry.\nN0(mol+): Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. \nN1: Cancer spread to 1 to 3 axillary (underarm) lymph node(s), and/or tiny amounts of cancer in internal mammary lymph nodes\nN1mi: Micrometastases in 1 to 3 lymph nodes under the arm. The areas of cancer spread in the lymph nodes are 2 mm or less across (but at least 200 cancer cells or 0.2mm across).\nN1a: Cancer has spread to 1 to 3 lymph nodes under the arm with at least one area of cancer spread greater than 2 mm across.\nN1b: Cancer has spread to internal mammary lymph nodes, but this spread could only be found on sentinel lymph node biopsy\nN1c: Both N1a and N1b apply.\nN2: Cancer has spread to 4 to 9 lymph nodes under the arm, or cancer has enlarged the internal mammary lymph nodes (either N2a or N2b, but not both).\nN2a: Cancer has spread to 4 to 9 lymph nodes under the arm, with at least one area of cancer spread larger than 2 mm.\nN2b: Cancer has spread to one or more internal mammary lymph nodes, causing them to become enlarged.\nN3: Any of the following:\nN3a: either:\nCancer has spread to 10 or more axillary lymph nodes, with at least one area of cancer spread greater than 2mm, OR cancer has spread to the lymph nodes under the collar bone (infraclavicular nodes), with at least one area of cancer spread\ngreater than 2mm.\nN3b: either:\nCancer is found in at least one axillary lymph node (with at least one area of cancer spread greater than 2 mm) and has enlarged the internal mammary lymph nodes, OR cancer has spread to 4 or more axillary lymph nodes (with at least one area of cancer spread greater than 2 mm), and tiny amounts of cancer are found in internal mammary lymph nodes on sentinel lymph node biopsy.\nN3c: Cancer has spread to the lymph nodes above the collar bone (supraclavicular nodes) with at least one area of cancer spread greater than 2mm.\n\nM\nMX: Distant spread (metastasis) cannot be assessed.\nM0: No distant spread is found on x-rays (or other imaging tests) or by physical exam.\ncM0(i+): Small numbers of cancer cells are found in blood or bone marrow (found only by special tests), or tiny areas of cancer spread (no larger than 0.2 mm) are found in lymph nodes away from the breast.\nM1: Cancer has spread to distant organs (most often to the bones, lungs, brain, or liver).\n\nStaging:\n\nStage \tT \tN \tM\n0 \tTis \tN0 \tM0\nIA \tT1 \tN0 \tM0\nIB \tT0 \tN1mi \tM0\n\tT1 \tN1mi \tM0\nIIA \tT0 \tN1 \tM0\n\tT1 \tN1 \tM0\n\tT2 \tN0 \tM0\nIIB \tT2 \tN1 \tM0\n\tT3 \tN0 \tM0\nIIIA \tT0 \tN2 \tM0\n\tT1 \tN2 \tM0\n\tT2 \tN2 \tM0\n\tT3 \tN1 \tM0\n\tT3 \tN2 \tM0\nIIIB \tT4 \tN0 \tM0\n\tT4 \tN1 \tM0\n\tT4 \tN2 \tM0\nIIIC \tAny T \tN3 \tM0\nIV \tAny T \tAny N \tM1\n\n",
        "misuse": "Using the TNM classification alone is not recommended in providing diagnostic assessment. Clinical evidence is required to back up the staging suggestions. ",
        "copyright": "© Cambio Healthcare Systems"
      }
    },
    "other_details": {
      "references": "Ref. 1: AJCC Cancer Staging Atlas A Companion to the Seventh Editions of the AJCC Cancer Staging Manual and Handbook\nCarolyn C. Compton David R Byrd; Julio Garcia-Aguilar; American Joint Committee on Cancer Content Provider. New York, NY : Springer New York : Imprint: Springer 2nd ed. 2012\n\nRef. 2: Theriault RL, Carlson RW, Allred C, et al. Breast Cancer, Version 3.2013: Featured Updates to the NCCN Guidelines. Journal of the National Comprehensive Cancer Network : JNCCN. 2013;11(7):753-761.\n\nRef. 3: Regular updates for breast cancer staging and treeatment can be found on the NCCN  (National Comprehensive Cancer Network) website, accessed at: www.nccn.org\n"
    }
  },
  "definition": {
    "data_bindings": {
      "gt0002": {
        "id": "gt0002",
        "model_id": "openEHR-EHR-OBSERVATION.tnm_breast_cancer_staging.v1",
        "template_id": "openEHR-EHR-OBSERVATION.tnm_breast_cancer_staging.v1",
        "type": "INPUT",
        "elements": {
          "gt0003": {
            "id": "gt0003",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0004": {
            "id": "gt0004",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0005]"
          },
          "gt0005": {
            "id": "gt0005",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0006]"
          }
        }
      },
      "gt0006": {
        "id": "gt0006",
        "model_id": "openEHR-EHR-OBSERVATION.tnm_breast_cancer_staging.v1",
        "template_id": "openEHR-EHR-OBSERVATION.tnm_breast_cancer_staging.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0007": {
            "id": "gt0007",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0004]"
          },
          "gt0008": {
            "id": "gt0008",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0005]"
          },
          "gt0009": {
            "id": "gt0009",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0006]"
          },
          "gt0010": {
            "id": "gt0010",
            "path": "/data[at0001]/events[at0002]/data[at0003]/items[at0007]"
          }
        }
      },
      "gt0030": {
        "id": "gt0030",
        "model_id": "openEHR-EHR-EVALUATION.tnm_breast_cancer_assessment.v1",
        "template_id": "openEHR-EHR-EVALUATION.tnm_breast_cancer_assessment.v1",
        "type": "OUTPUT",
        "elements": {
          "gt0031": {
            "id": "gt0031",
            "path": "/data[at0001]/items[at0002]"
          }
        }
      }
    },
    "default_actions": [
      "$gt0007|Tumour|=0|local::at0009|TX - Primary tumor cannot be assessed|",
      "$gt0008|Nodal involvement|=0|local::at0016|NX - Nearby lymph nodes cannot be assessed|",
      "$gt0009|Metastases|=0|local::at0032|MX - Distant spread (metastasis) cannot be assessed.|"
    ],
    "rules": {
      "gt0011": {
        "id": "gt0011",
        "priority": 26,
        "when": [
          "$gt0003|Tumour|!=null"
        ],
        "then": [
          "$gt0007|Tumour|=$gt0003|Tumour|"
        ]
      },
      "gt0012": {
        "id": "gt0012",
        "priority": 25,
        "when": [
          "$gt0004|Nodal involvement|!=null"
        ],
        "then": [
          "$gt0008|Nodal involvement|=$gt0004|Nodal involvement|"
        ]
      },
      "gt0013": {
        "id": "gt0013",
        "priority": 24,
        "when": [
          "$gt0005|Metastases|!=null"
        ],
        "then": [
          "$gt0009|Metastases|=$gt0005|Metastases|"
        ]
      },
      "gt0014": {
        "id": "gt0014",
        "priority": 23,
        "when": [
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "($gt0008|Nodal involvement|==1|local::at0017|N0 - Cancer has not spread to nearby lymph nodes.|)||(($gt0008|Nodal involvement|==2|local::at0018|N0(i+) - Cancer spread < 200 cells and is < 0.2 mm|)||($gt0008|Nodal involvement|==3|local::at0019|N0(mol+) - Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. |))",
          "$gt0007|Tumour|==2|local::at0011|Tis - Carcinoma in situ |"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=0|local::at0036|Stage 0|"
        ]
      },
      "gt0015": {
        "id": "gt0015",
        "priority": 22,
        "when": [
          "(($gt0008|Nodal involvement|==1|local::at0017|N0 - Cancer has not spread to nearby lymph nodes.|)||($gt0008|Nodal involvement|==3|local::at0019|N0(mol+) - Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. |))||($gt0008|Nodal involvement|==2|local::at0018|N0(i+) - Cancer spread < 200 cells and is < 0.2 mm|)",
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "$gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=1|local::at0037|Stage IA|"
        ]
      },
      "gt0016": {
        "id": "gt0016",
        "priority": 21,
        "when": [
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|)||($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|)",
          "$gt0008|Nodal involvement|==4|local::at0021|N1mi - Micrometastases in 1 to 3 lymph nodes underarm. |"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=2|local::at0038|Stage IB|"
        ]
      },
      "gt0017": {
        "id": "gt0017",
        "priority": 20,
        "when": [
          "($gt0008|Nodal involvement|==5|local::at0022|N1a - Spread to 1 to 3 lymph nodes with at least one area of cancer spread > 2 mm across.|)||(($gt0008|Nodal involvement|==6|local::at0023|N1b - Spread to internal mammary lymph nodes, but only found on sentinel lymph node biopsy|)||($gt0008|Nodal involvement|==7|local::at0024|N1c - Both N1a and N1b apply.|))",
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|)||($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|)"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=3|local::at0039|Stage IIA|"
        ]
      },
      "gt0018": {
        "id": "gt0018",
        "priority": 19,
        "when": [
          "!fired($gt0017)",
          "($gt0008|Nodal involvement|==1|local::at0017|N0 - Cancer has not spread to nearby lymph nodes.|)||(($gt0008|Nodal involvement|==2|local::at0018|N0(i+) - Cancer spread < 200 cells and is < 0.2 mm|)||($gt0008|Nodal involvement|==3|local::at0019|N0(mol+) - Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. |))",
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "$gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=3|local::at0039|Stage IIA|"
        ]
      },
      "gt0019": {
        "id": "gt0019",
        "priority": 18,
        "when": [
          "$gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|",
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "(($gt0008|Nodal involvement|==4|local::at0021|N1mi - Micrometastases in 1 to 3 lymph nodes underarm. |)||($gt0008|Nodal involvement|==5|local::at0022|N1a - Spread to 1 to 3 lymph nodes with at least one area of cancer spread > 2 mm across.|))||(($gt0008|Nodal involvement|==6|local::at0023|N1b - Spread to internal mammary lymph nodes, but only found on sentinel lymph node biopsy|)||($gt0008|Nodal involvement|==7|local::at0024|N1c - Both N1a and N1b apply.|))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=4|local::at0040|Stage IIB|"
        ]
      },
      "gt0020": {
        "id": "gt0020",
        "priority": 17,
        "when": [
          "!fired($gt0019)",
          "$gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|",
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "($gt0008|Nodal involvement|==1|local::at0017|N0 - Cancer has not spread to nearby lymph nodes.|)||(($gt0008|Nodal involvement|==2|local::at0018|N0(i+) - Cancer spread < 200 cells and is < 0.2 mm|)||($gt0008|Nodal involvement|==3|local::at0019|N0(mol+) - Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. |))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=4|local::at0040|Stage IIB|"
        ]
      },
      "gt0021": {
        "id": "gt0021",
        "priority": 16,
        "when": [
          "($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)||($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)",
          "($gt0008|Nodal involvement|==8|local::at0025|N2a - Spread to 4-9 lymph nodes underarm, with at least one area of cancer spread larger than 2 mm.|)||($gt0008|Nodal involvement|==9|local::at0026|N2b - Spread to one or more internal mammary lymph nodes, causing them to become enlarged.|)",
          "(($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|)||($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|))||($gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|)"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=5|local::at0041|Stage IIIA|"
        ]
      },
      "gt0022": {
        "id": "gt0022",
        "priority": 15,
        "when": [
          "!fired($gt0021)",
          "$gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|",
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "((($gt0008|Nodal involvement|==4|local::at0021|N1mi - Micrometastases in 1 to 3 lymph nodes underarm. |)||($gt0008|Nodal involvement|==5|local::at0022|N1a - Spread to 1 to 3 lymph nodes with at least one area of cancer spread > 2 mm across.|))||(($gt0008|Nodal involvement|==6|local::at0023|N1b - Spread to internal mammary lymph nodes, but only found on sentinel lymph node biopsy|)||($gt0008|Nodal involvement|==7|local::at0024|N1c - Both N1a and N1b apply.|)))||(($gt0008|Nodal involvement|==8|local::at0025|N2a - Spread to 4-9 lymph nodes underarm, with at least one area of cancer spread larger than 2 mm.|)||($gt0008|Nodal involvement|==9|local::at0026|N2b - Spread to one or more internal mammary lymph nodes, causing them to become enlarged.|))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=5|local::at0041|Stage IIIA|"
        ]
      },
      "gt0023": {
        "id": "gt0023",
        "priority": 14,
        "when": [
          "$gt0007|Tumour|==6|local::at0015|T4 (includes T4a, T4b, T4c, and T4d)|",
          "($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)||($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)",
          "((($gt0008|Nodal involvement|==3|local::at0019|N0(mol+) - Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. |)||($gt0008|Nodal involvement|==1|local::at0017|N0 - Cancer has not spread to nearby lymph nodes.|))||($gt0008|Nodal involvement|==2|local::at0018|N0(i+) - Cancer spread < 200 cells and is < 0.2 mm|))||(((($gt0008|Nodal involvement|==4|local::at0021|N1mi - Micrometastases in 1 to 3 lymph nodes underarm. |)||($gt0008|Nodal involvement|==5|local::at0022|N1a - Spread to 1 to 3 lymph nodes with at least one area of cancer spread > 2 mm across.|))||(($gt0008|Nodal involvement|==6|local::at0023|N1b - Spread to internal mammary lymph nodes, but only found on sentinel lymph node biopsy|)||($gt0008|Nodal involvement|==7|local::at0024|N1c - Both N1a and N1b apply.|)))||(($gt0008|Nodal involvement|==8|local::at0025|N2a - Spread to 4-9 lymph nodes underarm, with at least one area of cancer spread larger than 2 mm.|)||($gt0008|Nodal involvement|==9|local::at0026|N2b - Spread to one or more internal mammary lymph nodes, causing them to become enlarged.|)))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=6|local::at0042|Stage IIIB|"
        ]
      },
      "gt0024": {
        "id": "gt0024",
        "priority": 13,
        "when": [
          "($gt0009|Metastases|==1|local::at0033|M0 - No distant spread is found on x-rays (or other imaging tests) or by physical exam.|)||($gt0009|Metastases|==2|local::at0034|cM0(i+) - Small no. of cancer cells found in blood/bone marrow or tiny areas of cancer spread =< 0.2 mm in regional lymph nodes|)",
          "(($gt0008|Nodal involvement|==10|local::at0027|N3a|)||($gt0008|Nodal involvement|==11|local::at0028|N3b|))||($gt0008|Nodal involvement|==12|local::at0029|N3c|)",
          "((($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|)||($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|))||($gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|))||(($gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|)||($gt0007|Tumour|==6|local::at0015|T4 (includes T4a, T4b, T4c, and T4d)|))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=7|local::at0043|Stage IIIC|"
        ]
      },
      "gt0025": {
        "id": "gt0025",
        "priority": 12,
        "when": [
          "$gt0009|Metastases|==3|local::at0035|M1 - Cancer has spread to distant organs|",
          "($gt0008|Nodal involvement|==1|local::at0017|N0 - Cancer has not spread to nearby lymph nodes.|)||(($gt0008|Nodal involvement|==2|local::at0018|N0(i+) - Cancer spread < 200 cells and is < 0.2 mm|)||($gt0008|Nodal involvement|==3|local::at0019|N0(mol+) - Cancer cells cannot be seen in underarm lymph nodes but traces of cancer cells were detected using RT-PCR. |))",
          "((($gt0007|Tumour|==6|local::at0015|T4 (includes T4a, T4b, T4c, and T4d)|)||($gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|))||(($gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|)||($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|)))||($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|)"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=8|local::at0044|Stage IV|"
        ]
      },
      "gt0026": {
        "id": "gt0026",
        "priority": 11,
        "when": [
          "!fired($gt0025)",
          "$gt0009|Metastases|==3|local::at0035|M1 - Cancer has spread to distant organs|",
          "(($gt0008|Nodal involvement|==4|local::at0021|N1mi - Micrometastases in 1 to 3 lymph nodes underarm. |)||($gt0008|Nodal involvement|==5|local::at0022|N1a - Spread to 1 to 3 lymph nodes with at least one area of cancer spread > 2 mm across.|))||(($gt0008|Nodal involvement|==6|local::at0023|N1b - Spread to internal mammary lymph nodes, but only found on sentinel lymph node biopsy|)||($gt0008|Nodal involvement|==7|local::at0024|N1c - Both N1a and N1b apply.|))",
          "((($gt0007|Tumour|==6|local::at0015|T4 (includes T4a, T4b, T4c, and T4d)|)||($gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|))||(($gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|)||($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|)))||($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|)"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=8|local::at0044|Stage IV|"
        ]
      },
      "gt0027": {
        "id": "gt0027",
        "priority": 10,
        "when": [
          "!fired($gt0025)",
          "!fired($gt0026)",
          "$gt0009|Metastases|==3|local::at0035|M1 - Cancer has spread to distant organs|",
          "($gt0008|Nodal involvement|==8|local::at0025|N2a - Spread to 4-9 lymph nodes underarm, with at least one area of cancer spread larger than 2 mm.|)||($gt0008|Nodal involvement|==9|local::at0026|N2b - Spread to one or more internal mammary lymph nodes, causing them to become enlarged.|)",
          "((($gt0007|Tumour|==6|local::at0015|T4 (includes T4a, T4b, T4c, and T4d)|)||($gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|))||($gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|))||(($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|)||($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=8|local::at0044|Stage IV|"
        ]
      },
      "gt0028": {
        "id": "gt0028",
        "priority": 9,
        "when": [
          "!fired($gt0025)",
          "!fired($gt0026)",
          "!fired($gt0027)",
          "$gt0009|Metastases|==3|local::at0035|M1 - Cancer has spread to distant organs|",
          "(($gt0008|Nodal involvement|==10|local::at0027|N3a|)||($gt0008|Nodal involvement|==11|local::at0028|N3b|))||($gt0008|Nodal involvement|==12|local::at0029|N3c|)",
          "((($gt0007|Tumour|==6|local::at0015|T4 (includes T4a, T4b, T4c, and T4d)|)||($gt0007|Tumour|==5|local::at0014|T3 - Tumor is more than 5 cm across.|))||($gt0007|Tumour|==4|local::at0013|T2 - Tumor is more than 2 cm but not more than 5 cm (2 inches) across.|))||(($gt0007|Tumour|==3|local::at0012|T1 (includes T1a, T1b, and T1c)|)||($gt0007|Tumour|==1|local::at0010|T0 - No evidence of primary tumor|))"
        ],
        "then": [
          "$gt0010|Breast cancer stage|=8|local::at0044|Stage IV|"
        ]
      },
      "gt0032": {
        "id": "gt0032",
        "priority": 8,
        "when": [
          "$gt0010|Breast cancer stage|==0|local::at0036|Stage 0|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=0|local::at0003|99% Stage 0|"
        ]
      },
      "gt0033": {
        "id": "gt0033",
        "priority": 7,
        "when": [
          "($gt0010|Breast cancer stage|==1|local::at0037|Stage IA|)||($gt0010|Breast cancer stage|==2|local::at0038|Stage IB|)"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=1|local::at0004|92% Stage I|"
        ]
      },
      "gt0034": {
        "id": "gt0034",
        "priority": 6,
        "when": [
          "$gt0010|Breast cancer stage|==3|local::at0039|Stage IIA|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=2|local::at0005|82% Stage IIA|"
        ]
      },
      "gt0035": {
        "id": "gt0035",
        "priority": 5,
        "when": [
          "$gt0010|Breast cancer stage|==4|local::at0040|Stage IIB|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=3|local::at0006|65% Stage IIB|"
        ]
      },
      "gt0036": {
        "id": "gt0036",
        "priority": 4,
        "when": [
          "$gt0010|Breast cancer stage|==5|local::at0041|Stage IIIA|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=4|local::at0007|47% Stage IIIA|"
        ]
      },
      "gt0037": {
        "id": "gt0037",
        "priority": 3,
        "when": [
          "$gt0010|Breast cancer stage|==6|local::at0042|Stage IIIB|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=5|local::at0008|44% Stage IIIB|"
        ]
      },
      "gt0038": {
        "id": "gt0038",
        "priority": 2,
        "when": [
          "$gt0010|Breast cancer stage|==7|local::at0043|Stage IIIC|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=6|local::at0009|14-44% Stage IIIc|"
        ]
      },
      "gt0039": {
        "id": "gt0039",
        "priority": 1,
        "when": [
          "$gt0010|Breast cancer stage|==8|local::at0044|Stage IV|"
        ],
        "then": [
          "$gt0031|5 Year Survival rates|=7|local::at0010|14% Stage IV|"
        ]
      }
    }
  },
  "ontology": {
    "term_definitions": {
      "sv": {
        "id": "sv",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "TNM bröstcancer",
            "description": "American Joint Committee on Cancers (AJCC) TNM-klassifikation beskriver allvarlighetsgrad av bröstcancer baserat på tumörstorlek, lymfkörtelengagemang och förekomst av metastaser."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Tumörstorlek",
            "description": "Tumörstorlek, inklusive invasiv tillväxt in i omkringliggande vävnader."
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Lymfkörtelstatus",
            "description": "Lymfkörtelstatus; Engagemang av regionala lymfkörtlar, från 0 till flera."
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Fjärrmetastasering",
            "description": "Förekomst av fjärrmetastaser."
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Tumörstorlek",
            "description": "Tumörstorlek, inklusive invasiv tillväxt in i omkringliggande vävnader."
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Lymfkörtelstatus",
            "description": "Lymfkörtelstatus; Engagemang av regionala lymfkörtlar, från 0 till flera."
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Fjärrmetastasering",
            "description": "Förekomst av fjärrmetastaser."
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Stadium - bröstcancer",
            "description": "TNM-klassifikation med stadieindelning av bröstcancer"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "CDS Tumörstorlek"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "CDS Lymfkörtelstatus"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "CDS Fjärrmetastasering"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "CDS Stadium 0"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "CDS Stadium IA"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "CDS Stadium IB"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "CDS Stadium IIA - grupp 1"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "CDS Stadium IIA - grupp 2"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "CDS Stadium IIB - grupp 1"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "CDS Stadium IIB - grupp 2"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "CDS Stadium IIIA - grupp 1"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "CDS Stadium IIIA - grupp 2"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "CDS Stadium IIIB"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "CDS Stadium IIIC"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "CDS Stadium IV - grupp 1"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "CDS Stadium IV - grupp 2"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "CDS Stadium IV - grupp 3"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "CDS Stadium IV - grupp 4"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "5-årsöverlevnad",
            "description": "5-årsöverlevnad baserat på stadieindelning."
          },
          "gt0032": {
            "id": "gt0032",
            "text": "Stadium 0 - 5-årsöverlevnad",
            "description": ""
          },
          "gt0033": {
            "id": "gt0033",
            "text": "Stadium I - 5-årsöverlevnad",
            "description": ""
          },
          "gt0034": {
            "id": "gt0034",
            "text": "Stadium IIA - 5-årsöverlevnad",
            "description": ""
          },
          "gt0035": {
            "id": "gt0035",
            "text": "Stadium IIB - 5-årsöverlevnad",
            "description": ""
          },
          "gt0036": {
            "id": "gt0036",
            "text": "Stadium IIIA  - 5-årsöverlevnad",
            "description": ""
          },
          "gt0037": {
            "id": "gt0037",
            "text": "Stadium IIIB  - 5-årsöverlevnad",
            "description": ""
          },
          "gt0038": {
            "id": "gt0038",
            "text": "Stadium IIIC  - 5-årsöverlevnad",
            "description": ""
          },
          "gt0039": {
            "id": "gt0039",
            "text": "Stadium IV - 5-årsöverlevnad",
            "description": ""
          }
        }
      },
      "en": {
        "id": "en",
        "terms": {
          "gt0001": {
            "id": "gt0001",
            "text": "TNM Breast",
            "description": "The American Joint Committee on Cancer (AJCC) TNM staging system reports on the severity of breast cancer based on tumor, lymph node and metastasis characteristics."
          },
          "gt0003": {
            "id": "gt0003",
            "text": "Tumour",
            "description": "The letter T followed by a number from 0 to 4 describes the main\r\n(primary) tumor's size and spread to the skin or to the chest wall under\r\nthe breast. Higher T numbers mean a larger tumor and/or wider spread to tissues near the breast.\r\n"
          },
          "gt0004": {
            "id": "gt0004",
            "text": "Nodal involvement",
            "description": "N classification has 3 main divisions with subdivisions as described. An area of cancer spread < 0.2 mm (or fewer than 200 cells) doesn't affect the stage, but is recorded with abbreviations (i+ or mol+) that indicate the type of special test used to find the spread but this level of staging does not affect the overall staging classification of the N subset.\r\nIf the area of cancer spread is > = 0.2 mm (or 200 cells), but still not larger than 2 mm, it is called a micrometastasis. Micrometastases are counted only if there aren't any larger areas of cancer spread (>2mm)."
          },
          "gt0005": {
            "id": "gt0005",
            "text": "Metastases",
            "description": "Distant metastases. "
          },
          "gt0007": {
            "id": "gt0007",
            "text": "Tumour",
            "description": "The letter T followed by a number from 0 to 4 describes the main\r\n(primary) tumor's size and spread to the skin or to the chest wall under\r\nthe breast. Higher T numbers mean a larger tumor and/or wider spread to tissues near the breast.\r\n"
          },
          "gt0008": {
            "id": "gt0008",
            "text": "Nodal involvement",
            "description": "N classification has 3 main divisions with subdivisions as described. An area of cancer spread < 0.2 mm (or fewer than 200 cells) doesn't affect the stage, but is recorded with abbreviations (i+ or mol+) that indicate the type of special test used to find the spread but this level of staging does not affect the overall staging classification of the N subset.\r\nIf the area of cancer spread is > = 0.2 mm (or 200 cells), but still not larger than 2 mm, it is called a micrometastasis. Micrometastases are counted only if there aren't any larger areas of cancer spread (>2mm)."
          },
          "gt0009": {
            "id": "gt0009",
            "text": "Metastases",
            "description": "Distant metastases. "
          },
          "gt0010": {
            "id": "gt0010",
            "text": "Breast cancer stage",
            "description": "Breast cancer staging made up of the TNM groups"
          },
          "gt0011": {
            "id": "gt0011",
            "text": "Set Tumour"
          },
          "gt0012": {
            "id": "gt0012",
            "text": "Set Nodes"
          },
          "gt0013": {
            "id": "gt0013",
            "text": "Set Metastases"
          },
          "gt0014": {
            "id": "gt0014",
            "text": "Set Stage 0"
          },
          "gt0015": {
            "id": "gt0015",
            "text": "Set Stage IA"
          },
          "gt0016": {
            "id": "gt0016",
            "text": "Set Stage IB"
          },
          "gt0017": {
            "id": "gt0017",
            "text": "Set Stage IIA - group 1"
          },
          "gt0018": {
            "id": "gt0018",
            "text": "Set Stage IIA - group 2"
          },
          "gt0019": {
            "id": "gt0019",
            "text": "Set Stage IIB - group 1"
          },
          "gt0020": {
            "id": "gt0020",
            "text": "Set Stage IIB - group 2"
          },
          "gt0021": {
            "id": "gt0021",
            "text": "Set Stage IIIA - group 1"
          },
          "gt0022": {
            "id": "gt0022",
            "text": "Set Stage IIIA - group 2"
          },
          "gt0023": {
            "id": "gt0023",
            "text": "Set Stage IIIB"
          },
          "gt0024": {
            "id": "gt0024",
            "text": "Set Stage IIIC"
          },
          "gt0025": {
            "id": "gt0025",
            "text": "Set Stage IV - group 1"
          },
          "gt0026": {
            "id": "gt0026",
            "text": "Set Stage IV - group 2"
          },
          "gt0027": {
            "id": "gt0027",
            "text": "Set Stage IV - group 3"
          },
          "gt0028": {
            "id": "gt0028",
            "text": "Set Stage IV - group 4"
          },
          "gt0031": {
            "id": "gt0031",
            "text": "5 Year Survival rates",
            "description": "5 Year survival according to the Stage of breast cancer"
          },
          "gt0032": {
            "id": "gt0032",
            "text": "Stage 0 - 5 year survival"
          },
          "gt0033": {
            "id": "gt0033",
            "text": "Stage I - 5 year survival"
          },
          "gt0034": {
            "id": "gt0034",
            "text": "Stage IIA - 5 year survival"
          },
          "gt0035": {
            "id": "gt0035",
            "text": "Stage IIB - 5 year survival"
          },
          "gt0036": {
            "id": "gt0036",
            "text": "Stage IIIA  - 5 year survival"
          },
          "gt0037": {
            "id": "gt0037",
            "text": "Stage IIIB  - 5 year survival"
          },
          "gt0038": {
            "id": "gt0038",
            "text": "Stage IIIC  - 5 year survival"
          },
          "gt0039": {
            "id": "gt0039",
            "text": "Stage IV - 5 year survival"
          }
        }
      }
    }
  }
}
